M. Dumoulin

The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.

A. Adam, D. Lamontagne, N. Yamaguchi, 2005, Canadian journal of physiology and pharmacology.

Omapatrilat: A new tool for understanding metabolism of bradykinin at the endothelium level

A. Adam, G. Molinaro, D. Lamontagne, 2001, Current hypertension reports.

Antiarrhythmic effects of ceruloplasmin during reperfusion in the ischemic isolated rat heart.

R. Nadeau, M. Mateescu, R. Chahine, 1995, Canadian journal of physiology and pharmacology.

Metabolism of bradykinin by the rat coronary vascular bed.

A. Adam, C. Blais, D. Lamontagne, 1998, Cardiovascular research.

Comparison of a Vasopeptidase Inhibitor with Neutral Endopeptidase and Angiotensin-Converting Enzyme Inhibitors on Bradykinin Metabolism in the Rat Coronary Bed

J. Rouleau, A. Adam, D. Lamontagne, 2001, Journal of cardiovascular pharmacology.

Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction.

J. Rouleau, A. Adam, D. Lamontagne, 2003, Canadian journal of physiology and pharmacology.

Comparative antioxidant and cardioprotective effects of ceruloplasmin, superoxide dismutase and albumin.

R. Nadeau, M. Mateescu, R. Chahine, 1996, Arzneimittel-Forschung.

Toxicokinetic Modeling of Parathion and its Metabolites in Humans for the Determination of Biological Reference Values

M. Bouchard, G. Carrier, R. Brunet, 2004, Toxicology mechanisms and methods.

A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers.

Gaétan Carrier, M. Bouchard, G. Carrier, 2003, Toxicological sciences : an official journal of the Society of Toxicology.

Joint chromatographic purification of bovine serum ceruloplasmin and amineoxidase.

M. Mateescu, B. Mondovì, O. Befani, 1994, Preparative biochemistry.